NCT01057407View on ClinicalTrials.gov

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency
Interventions
DRUG

ASP1585

oral

DRUG

Sevelamer hydrochloride

oral

Trial Locations (3)

Unknown

Chūbu

Kantou

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY